Stocks To Watch: Sanofi SA Rights

|
 |  Includes: GCVRZ
by: SA Stocks To Watch

Summary

SA contributors highlight a stock to watch for unusual movement, share their bias (long/short) and brief comments.

Stocks are listed alphabetically, and you can click on the contributors' name to read more articles by that author.

Discuss today's idea and ask questions in the comments.

Track today's stock to watch here. To send in your own ideas for Monday's Stocks To Watch, email stockstowatch@seekingalpha.com before 6:00 am ET Monday.

Sanofi SA Rights (NASDAQ:GCVRZ) - long - Chris DeMuth Jr.

  • Up by over 40% year-to-date on renewed optimism regarding the FDA
  • A petition to the White House demands Lemtrada approval
  • SNY took a 132 million euro charge based on Lemtrada-linked liability
  • SNY has increased job openings related to US Lemtrada sales
  • This is my best long idea for 2014 in part due to >50% FDA approval odds
  • It has positive expectancy (+EV) in a long with little market or macro risk

Editor's Note: This article covers one or more stocks trading at less than $1 per share and/or with less than a $100 million market cap. Please be aware of the risks associated with these stocks.